Company Profile

  1. You are here:    Home
  2. Search Databases
  3. Search Company Registry
  4. Company Profile

Solentix Biosciences Inc
Profile last edited on: 12/16/14      CAGE:       UEI: MW8SKKW7AJ51

Business Identifier: NO Business Identifier is currently available for this company.
Year Founded
2002
First Award
2003
Latest Award
2006
Program Status
Inactive
Popularity Index

Edit Company Profile

Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
  Explanation Edit

Location Information

4058 NE Lookout Lane
Poulsbo, WA 98370
   (360) 779-6220
   N/A
   N/A
Location: Single
Congr. District: 06
County: Kitsap

Public Profile

Previously located in Ohio, Solentix's core business strategy is to develop therapeutics for major unmet clinical needs for chronic central nervous system ("CNS") diseases

Extent of SBIR involvement

User Avatar
Phase I Awards
3
Phase II Awards
1
Conversion Rate
33.33%
Phase I Dollars
$308,789
Phase II Dollars
$783,774
Total Awarded
$1,092,563

Synopsis: Awardee Business Condition

Employee Range
5-9
Revenue Range
.5M-1M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects
Year Phase Agency Total Amount
2006 2 NIH $883,774
Project Title: Novel 5-HT treatments for METH post-addiction therapy
2003 1 NIH $100,000
Project Title: Novel Crf Receptor Antagonists to Treat Stimulant Abuse
2003 1 NIH $108,789
Project Title: Novel DA D1 treatments for METH post-addiction therapy

Key People / Management

  Clark Tedford -- President

  Stephen Yates

Company News

There are no news available.